Elevated CAPN2 levels are linked to advanced tumor stages and poor prognosis, making the METTL16–MROH8–TBP–CAPN2 axis a potential therapeutic target for pancreatic cancer. The gene discussed is CAPN2; the disease is pancreatic neoplasm.